Transition Planning Outcomes Therapy

Transition Planning Outcomes Therapy 37 Kalantar-Zadeh K, Kovesdy CP, Streja E, et al Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney disease Results were similar in analyses of the PARAGON-HF trial, with outcomes similar among participants who experienced an eGFR decline (RR = 084; 95% CI, 052-136) or no eGFR decline (RR = 087; 95%

Getting Started Outcomes Therapy Jim Dague, CEO of Goshen, Ind , based IU Goshen Health, announced his retirement earlier this month, following a 16-year tenure with the health system During his time as the health system's top lead

Transition Outcomes Therapy
Comments are closed.